Preventing vincristine administration errors.

The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) issued this alert to bring attention to a rare but potentially severe administration error reported with the cancer drug vincristine. A previous editorial discusses similar errors. Note: This alert has been retired effective August 2016. Please refer to the information link below for further details.